Form 8-K - Current report:
SEC Accession No. 0001213900-17-013528
Filing Date
2017-12-21
Accepted
2017-12-21 16:15:41
Documents
1
Period of Report
2017-12-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k122017_actiniumpharma.htm 8-K 23062
  Complete submission text file 0001213900-17-013528.txt   24229
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 171269617
SIC: 2834 Pharmaceutical Preparations